230 related articles for article (PubMed ID: 38104183)
1. Role of Fra-2 in cancer.
Rampioni Vinciguerra GL; Capece M; Scafetta G; Rentsch S; Vecchione A; Lovat F; Croce CM
Cell Death Differ; 2024 Feb; 31(2):136-149. PubMed ID: 38104183
[TBL] [Abstract][Full Text] [Related]
2. Liver cancer development driven by the AP-1/c-Jun~Fra-2 dimer through c-Myc.
Bakiri L; Hasenfuss SC; Guío-Carrión A; Thomsen MK; Hasselblatt P; Wagner EF
Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2404188121. PubMed ID: 38657045
[TBL] [Abstract][Full Text] [Related]
3. Developmental expression and activities of specific fos and jun proteins are functionally related to osteoblast maturation: role of Fra-2 and Jun D during differentiation.
McCabe LR; Banerjee C; Kundu R; Harrison RJ; Dobner PR; Stein JL; Lian JB; Stein GS
Endocrinology; 1996 Oct; 137(10):4398-408. PubMed ID: 8828501
[TBL] [Abstract][Full Text] [Related]
4. The repertoire of fos and jun proteins expressed during the G1 phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation.
Cook SJ; Aziz N; McMahon M
Mol Cell Biol; 1999 Jan; 19(1):330-41. PubMed ID: 9858557
[TBL] [Abstract][Full Text] [Related]
5. Effect of estrogen and tamoxifen on the expression pattern of AP-1 factors in MCF-7 cells: role of c-Jun, c-Fos, and Fra-1 in cell cycle regulation.
Babu RL; Naveen Kumar M; Patil RH; Devaraju KS; Ramesh GT; Sharma SC
Mol Cell Biochem; 2013 Aug; 380(1-2):143-51. PubMed ID: 23625206
[TBL] [Abstract][Full Text] [Related]
6. DEP-induced fra-1 expression correlates with a distinct activation of AP-1-dependent gene transcription in the lung.
Zhang Q; Kleeberger SR; Reddy SP
Am J Physiol Lung Cell Mol Physiol; 2004 Feb; 286(2):L427-36. PubMed ID: 14565943
[TBL] [Abstract][Full Text] [Related]
7. Fos family members: regulation, structure and role in oncogenic transformation.
Tulchinsky E
Histol Histopathol; 2000 Jul; 15(3):921-8. PubMed ID: 10963134
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional activation of the fra-1 gene by AP-1 is mediated by regulatory sequences in the first intron.
Bergers G; Graninger P; Braselmann S; Wrighton C; Busslinger M
Mol Cell Biol; 1995 Jul; 15(7):3748-58. PubMed ID: 7791782
[TBL] [Abstract][Full Text] [Related]
9. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
[TBL] [Abstract][Full Text] [Related]
10. Expression of Jun and Fos proteins in ovarian tumors of different malignant potential and in ovarian cancer cell lines.
Hein S; Mahner S; Kanowski C; Löning T; Jänicke F; Milde-Langosch K
Oncol Rep; 2009 Jul; 22(1):177-83. PubMed ID: 19513521
[TBL] [Abstract][Full Text] [Related]
11. Restraint-induced fra-2 and c-fos expression in the rat forebrain: relationship to stress duration.
Weinberg MS; Girotti M; Spencer RL
Neuroscience; 2007 Dec; 150(2):478-86. PubMed ID: 17936518
[TBL] [Abstract][Full Text] [Related]
12. Cholesterol sulfate stimulates involucrin transcription in keratinocytes by increasing Fra-1, Fra-2, and Jun D.
Hanley K; Wood L; Ng DC; He SS; Lau P; Moser A; Elias PM; Bikle DD; Williams ML; Feingold KR
J Lipid Res; 2001 Mar; 42(3):390-8. PubMed ID: 11254751
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of Fos-related antigen-1 in head and neck squamous cell carcinoma.
Mangone FR; Brentani MM; Nonogaki S; Begnami MD; Campos AH; Walder F; Carvalho MB; Soares FA; Torloni H; Kowalski LP; Federico MH
Int J Exp Pathol; 2005 Aug; 86(4):205-12. PubMed ID: 16045542
[TBL] [Abstract][Full Text] [Related]
14. Heterodimerization with Fra-1 cooperates with the ERK pathway to stabilize c-Jun in response to the RAS oncoprotein.
Talotta F; Mega T; Bossis G; Casalino L; Basbous J; Jariel-Encontre I; Piechaczyk M; Verde P
Oncogene; 2010 Aug; 29(33):4732-40. PubMed ID: 20543861
[TBL] [Abstract][Full Text] [Related]
15. The nuclear oncoprotein Fra-1: a transcription factor knocking on therapeutic applications' door.
Talotta F; Casalino L; Verde P
Oncogene; 2020 Jun; 39(23):4491-4506. PubMed ID: 32385348
[TBL] [Abstract][Full Text] [Related]
16. Fra-1 negatively regulates lipopolysaccharide-mediated inflammatory responses.
Morishita H; Saito F; Kayama H; Atarashi K; Kuwata H; Yamamoto M; Takeda K
Int Immunol; 2009 Apr; 21(4):457-65. PubMed ID: 19251936
[TBL] [Abstract][Full Text] [Related]
17. Cell transformation by v-Rel reveals distinct roles of AP-1 family members in Rel/NF-kappaB oncogenesis.
Liss AS; Tiwari R; Kralova J; Bose HR
Oncogene; 2010 Sep; 29(35):4925-37. PubMed ID: 20562914
[TBL] [Abstract][Full Text] [Related]
18. ERK signaling regulates tumor promoter induced c-Jun recruitment at the Fra-1 promoter.
Adiseshaiah P; Li J; Vaz M; Kalvakolanu DV; Reddy SP
Biochem Biophys Res Commun; 2008 Jun; 371(2):304-8. PubMed ID: 18435914
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the role of activator protein-1 on transcription of the mouse steroidogenic acute regulatory protein gene.
Manna PR; Eubank DW; Stocco DM
Mol Endocrinol; 2004 Mar; 18(3):558-73. PubMed ID: 14673133
[TBL] [Abstract][Full Text] [Related]
20. Genetic disruption of Fra-1 decreases susceptibility to endotoxin-induced acute lung injury and mortality in mice.
Vaz M; Reddy NM; Rajasekaran S; Reddy SP
Am J Respir Cell Mol Biol; 2012 Jan; 46(1):55-62. PubMed ID: 21816965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
